ASTS
AST SpaceMobile, Inc.
ASTS offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
MCHP
Microchip Technology Incorporated
MCHP has the edge over ASTS overall, supported by lower modeled downside and stronger modeled upside.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
MCHP Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Stable |
MCHP's revenue, profitability and cash flow are currently strong, and its balance sheet is stable.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
MCHP PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 15x | $62.08 | — |
| Cheap | 21x | $28.42 | -54% |
| Fair | 40x | $53.17 | -14% |
| Current | 47x | $62.08 | — |
| Expensive | 104x | $138 | +122% |
Historical ranges are pointers, not guarantees.
MCHP's PE is in its fair range at 47x. If earnings grow as analysts expect, today's price would be 15x next year's earnings, in its cheap range.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
MCHP Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
Analysts expect strong earnings and revenue growth for MCHP, with profitability improving.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
MCHP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.02 | +202% |
| Q3 2026 | $1.33 | +$1.78 |
| Q2 2026 | $0.68 | +$1.02 |
| Q1 2026 | $0.22 | +$0.23 |
| Q4 2025 | -$0.29 | -151% |
| Q3 2025 | -$0.45 | -131% |
| Q2 2025 | -$0.34 | -114% |
| Q1 2025 | -$0.01 | -100% |
| Q4 2024 | $0.57 | -87% |
MCHP has the edge over ASTS on earnings quality, reporting a profit while its opponent remains loss making.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over MCHP on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
MCHP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.6B | +42% |
| Q2 2026 | $1.5B | +38% |
| Q1 2026 | $1.3B | +35% |
| Q4 2025 | $1.2B | +16% |
| Q3 2025 | $1.1B | -2% |
| Q2 2025 | $1.1B | -13% |
| Q1 2025 | $970.5M | -27% |
| Q4 2024 | $1B | -42% |
MCHP's revenue is recovering but still below its 2023 peak: $1.6B last quarter, up 42% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 29% | +21 points |
| Q2 2026 | 23% | +20 points |
| Q1 2026 | 17% | +27 points |
| Q4 2025 | 13% | +9.8 points |
| Q3 2025 | 7.8% | -4.8 points |
| Q2 2025 | 3% | -15 points |
| Q1 2025 | -10% | -30 points |
| Q4 2024 | 3% | -27 points |
MCHP has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
MCHP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $396.1M | +668% |
| Q2 2026 | $497.6M | +93% |
| Q1 2026 | $242.8M | +27% |
| Q4 2025 | $318.9M | +26% |
| Q3 2025 | $51.6M | +126% |
| Q2 2025 | $257.7M | -15% |
| Q1 2025 | $191.7M | -51% |
| Q4 2024 | $253.4M | -68% |
MCHP has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has 300M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
MCHP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +100K shares |
| 1 year | +1% | +5.6M shares |
| 3 years | +0.3% | +1.4M shares |
| 5 years | -2.7% | -15.3M shares |
| Available history | +6.6% | +34M shares |
MCHP has the edge over ASTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $6.5M |
| Q3 2024 | $17.3M |
| Q2 2024 | $72.7M |
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MCHP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.8x | Moderate |
| Q2 2026 | 3.5x | Elevated |
| Q1 2026 | 4.5x | High |
| Q4 2025 | 5.9x | High |
| Q3 2025 | 6.7x | High |
| Q2 2025 | 5.8x | High |
| Q1 2025 | 4.6x | High |
| Q4 2024 | 4.3x | High |
MCHP's net debt is about 2.8 years of its operating earnings (EBITDA), down from 6.7 years a year ago.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
MCHP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.7 | Neutral |
| Stochastic | 28.2 | Neutral |
MCHP's weekly RSI is 39 (neutral) and its Stochastic is 28 (neutral).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
MCHP PE vs Technology Sector
| Metric | MCHP | Sector median | Relative |
|---|---|---|---|
| PE | 47x | 28x | 68% above |
| PE % | 61 | 35 | 26 pts above |
MCHP is trading at 47x earnings, a 68% premium to the Technology sector's median of 28x.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has the edge over MCHP on trend strength, trading above more of its moving averages.
MCHP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $72.7 | 15% below |
| 20 week MA | $76.2 | 18% below |
| 50 week MA | $77.2 | 20% below |
| 100 week MA | $68.2 | 9% below |
| 200 week MA | $75.2 | 17% below |
MCHP is in a downtrend: it's below all five of its weekly moving averages, and 17% below its 200-week average.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.
MCHP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $52.7 | $68.4 | +30% |
| 2021 | $68.4 | $86.9 | +27% |
| 2022 | $86.9 | $69.9 | -20% |
| 2023 | $69.9 | $90.2 | +29% |
| 2024 | $90.2 | $58.3 | -35% |
| 2025 | $58.3 | $64.9 | +11% |
| 2026 YTD | $64.9 | $62.1 | -4.4% |
MCHP has the edge over ASTS on returns for 2026, with the stronger performance.